Home » Topics » Science » Drug design, drug delivery and technologies

Drug design, drug delivery and technologies
RSS

BioWa licenses Potelligent to GSK for antibody development and commercialization

Dec. 12, 2008

Genentech licenses ImmunoGen's TAP technology to develop anticancer therapeutics

Dec. 11, 2008

Cerus receives expanded label claim for Intercept Blood System

Dec. 5, 2008

Covidien licenses worldwide rights to DepoMed's AcuForm drug delivery technology

Nov. 27, 2008

NIH awards SBIR grant to BioSante to develop pulmonary delivery of IFN-alpha

Nov. 18, 2008

Athersys achieves development milestone in Bristol-Myers discovery alliance

Nov. 17, 2008

Telik enters discovery agreement for musculoskeletal and autoimmune diseases

Nov. 14, 2008

SurModics acquires drug delivery technology from PR Pharmaceuticals

Nov. 6, 2008

MonoSol and Midatech sign agreement to develop therapeutic nanoparticles in thin film

Nov. 5, 2008

BioWa licenses Potelligent to KaloBios

Oct. 30, 2008

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 21, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 21, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...